Public Company Healthcare

Bausch + Lomb

Bridgewater, New Jersey, United States

Leading global eye-health company dedicated to protecting and enhancing the gift of sight, with a portfolio spanning contact lenses, lens care, ophthalmic pharmaceuticals, over-the-counter eye-care products, and ophthalmic surgical devices and instruments.

Focus Areas
Contact lenses, Lens care, Ophthalmic pharmaceuticals
Website
www.bausch.com

Tracked deals

3

3 tracked deals across 2023-2025.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout

Bausch + Lomb Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Bausch + Lomb. 1 2023 1 2024 1 2025

Supporting Data

Recent Transactions

  • Bausch + Lomb Affiliate Acquires Whitecap Biosciences
    January 13, 2025
    Buyer
    Bausch + Lomb Corporation
    Target
    Whitecap Biosciences, LLC
    Industry
    Pharmaceuticals
    Location
    United States
    Type
    Buyout

    An affiliate of Bausch + Lomb Corporation has acquired clinical-stage Whitecap Biosciences, LLC, which is developing two ophthalmic therapies (WB007 and WB006) for glaucoma and geographic atrophy. The deal strengthens Bausch + Lomb's clinical-stage pipeline — Whitecap completed a Phase 2 study for WB007 and plans additional trials for both indications.

  • Bausch + Lomb Acquires Trukera Medical
    July 23, 2024
    Buyer
    Bausch + Lomb Corporation
    Target
    Trukera Medical
    Seller
    AccelMed Partners, Other shareholders
    Industry
    Medical Devices
    Location
    California, United States
    Type
    Buyout

    Bausch + Lomb Corporation announced that an affiliate has acquired Trukera Medical (formerly TearLab) from private equity owner AccelMed Partners and other shareholders. The tuck‑in acquisition brings the ScoutPro point‑of‑care tear osmolarity diagnostic into Bausch + Lomb’s surgical portfolio to strengthen preoperative dry eye assessment and expand its U.S. surgical presence.

  • Bausch + Lomb Acquires AcuFocus, Inc.
    January 17, 2023
    Buyer
    Bausch + Lomb Corporation
    Target
    AcuFocus, Inc.
    Seller
    Parent company of AcuFocus
    Industry
    Medical Devices
    Location
    California, United States
    Type
    Buyout

    Bausch + Lomb Corporation has acquired AcuFocus, Inc. through an affiliate via a merger with AcuFocus’s parent company. The acquisition adds AcuFocus’s IC‑8 Apthera small‑aperture extended‑depth‑of‑focus intraocular lens to Bausch + Lomb’s surgical portfolio to expand capabilities in premium cataract IOL offerings.

Related Acquisition Pages

Medical Devices Buyers & Acquisitions 2 tracked deals by Bausch + Lomb. Pharmaceuticals Buyers & Acquisitions 1 tracked deal by Bausch + Lomb. Acquisitions in California 2 tracked deals by Bausch + Lomb.

Related articles

Selling a company? Get in front of buyers like Bausch + Lomb

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →